{
    "title": "Multiple sclerosis - Dr. Coimbra Video in Portuguese concerning big pharma",
    "slug": "multiple-sclerosis-dr-coimbra-video-in-portuguese-concerning-big-pharma",
    "aliases": [
        "/Multiple+sclerosis+-+Dr+Coimbra+Video+in+Portuguese+concerning+big+pharma+-+May+2019",
        "/10758"
    ],
    "tiki_page_id": 10758,
    "date": "2019-05-10",
    "tags": [
        "autoimmune",
        "high dose",
        "intervention",
        "multiple sclerosis"
    ]
}


#### [YouTube Starts about 15 minutes](https://www.youtube.com/watch?v=34LrnwX3Xzc&fbclid=IwAR2SzLsz11JVHP6S_W31HzHOTEV7IZGVhdOhvq5Xv_mxAkLGsYu18W9pJBQ) 35 minutes long

"Dr. Cicero talks about how the pharmaceutical industry calls multiple sclerosis patients from "Therapeutic market":

""A indústria farmacêutica espera ganhar, apenas com a esclerose múltipla em 2024 quase 25 bilhões de dólares, e está chamando os investidores para comprar ações. Eles chamam os pacientes com EM de "mercado terapêutico da esclerose múltipla". No ano passado o Brasil gastou com medicamentos biológicos o número astronômica de 2.8 bilhões de dólares. Em um único ano, um país, pagou a 3 EMPRESAS DE MEDICAMENTOS DE ALTO CUSTO 2.8 bilhões de dólares."

 **GOOGLE Translate** 

"The pharmaceutical industry expects to gain, with multiple sclerosis alone in 2024 nearly $ 25 billion, and is calling on investors to buy stocks." They call MS patients a "therapeutic market for multiple sclerosis." with biologic drugs, the astronomical figure of $ 2.8 billion. In one year, a country paid $ 2.8 billion to high-priced drugs.

* "Biological medicines, which have side effects that can kill. But it's okay if the patient dies, the pharmaceutical industry is protected by the package leaflet, with a huge list of side effects, which includes sudden death. And nothing happens, because she's protected from a legal point of view.""

<!-- ~tc~ (alias(Multiple sclerosis - Dr. Coimbra Video in Portuguese - May 2019)) ~/tc~ -->